Obsessive-Compulsive Disorder – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of obsessive-compulsive disorder (OCD) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the total 12-month prevalence and the severity of OCD for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets.
Clarivate Epidemiology’s OCD forecast will answer the following question:
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of OCD over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
Clarivate Epidemiology provides at least 10 years of forecast data for the following OCD patient populations:
- Total 12-month prevalent cases.
- Total 12-month prevalent cases by severity—mild, moderate, severe.
Note: Coverage may vary by country and region.
Table of contents
Mariam Sophia, M.P.H., Epidemiologist. Prior to studying epidemiology, she had a private clinical practice and later worked as a tutor at Manipal College of Dental Sciences. She has experience working in COVID-19 care centers and in Tele ICU. She holds an M.P.H. from India’s Manipal University, where she specialized in epidemiology. Her research thesis assessed the nutritional status of tribal children less than five years old. She has interned in the government-run tuberculosis program (RNTCP).
Mudasir Khan, M.P.H., Manager, Epidemiology. Before joining Clarivate, Mr. Khan worked as a team lead at IKS Health, an organization that works on patient-level healthcare data management. His areas of expertise at the Clarivate epi team are oncology and psychiatry. He holds a master’s degree in public health from the Tata Institute of Social Sciences in Mumbai.